Healthy Participants

The Strong Gut Study Part 2

3 night stay + 1 night + 1 night, 11 follow ups

Help Test a New Potential drug for the Treatment of IBD

This clinical study is evaluating a potential new drug to treat IBD. IBD is a term used to describe conditions that cause abdominal pain and diarrhoea, among other symptoms.

The study drug is designed to reduce the inflammatory response that causes IBD symptoms

The study is a randomised, double-blind, placebo-controlled trial. The purpose of this study is to assess the safety and tolerability of a single dose in healthy men and women with a BMI of 18–35.

Schedule

Cohort 2.2

Check In

Oct 15th

Check Out

Oct 18th

Oct 23rd

-

Check In

Oct 30th

Check Out

Oct 31st

Nov 06th

-

Check In

Nov 12th

Check Out

Nov 13th

Nov 20th, 27th, Dec 04th, 11th, 25th, Jan 08th, Feb 05th, Mar 05th, Apr 02nd

Cohort 3.1

Check In

Nov 01st

Check Out

Nov 04th

Nov 09th

-

Check In

Nov 16th

Check Out

Nov 17th

Nov 23rd

-

Check In

Nov 30th

Check Out

Dec 01st

Dec 07th, 14th, 21st, 28th, Jan 11th, 25th, Feb 22nd, Mar 22nd, Apr 19th

To Qualify, You Must

New healthy volunteer study coming soon.

Spots are limited. Find out if you qualify today!